Difference between revisions of "Fumarola C, et al. Biochem. Pharmacol. (2014) cited as Ref 361 in DOI: 10.1038/s41392-020-0110-5 (Q9624)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 24863259, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Fourth Author string (P152): Alfieri RR, #quickstatements; #temporary_batch_1590155310798)
 
(5 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2014
Timestamp+2014-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2014 / rank
 +
Normal rank
Property / Published In Name String
 +
Biochem. Pharmacol.
Property / Published In Name String: Biochem. Pharmacol. / rank
 +
Normal rank
Property / Volume
 +
90
Property / Volume: 90 / rank
 +
Normal rank
Property / title
 +
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer (English)
Property / title: Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer (English) / rank
 +
Normal rank
Property / Page(s)
 +
197-207
Property / Page(s): 197-207 / rank
 +
Normal rank
Property / Fourth Author string
 +
Alfieri RR
Property / Fourth Author string: Alfieri RR / rank
 +
Normal rank

Latest revision as of 13:49, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Fumarola C, et al. Biochem. Pharmacol. (2014) cited as Ref 361 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Fumarola C
    0 references
    Bonelli MA
    0 references
    Petronini PG
    0 references
    0 references
    2014
    0 references
    Biochem. Pharmacol.
    0 references
    90
    0 references
    Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer (English)
    0 references
    197-207
    0 references
    Alfieri RR
    0 references